Literature DB >> 8260963

Ivermectin in goat plasma and milk after subcutaneous injection.

M Alvinerie1, J F Sutra, P Galtier.   

Abstract

The pharmacokinetics and mammary excretion of ivermectin were determined in goats following a single sc administration (0.2 mg/kg). Kinetic analysis of plasma and milk levels was performed using a 1-compartment model. The maximum plasma concentration of 6.12 ng/ml occurred at 2.85 d; the half-life of 4.03 d was similar to the value in sheep (3.68 d). Ivermectin was detected in the milk at the first sampling time and thereafter for at least 25 d. Comparison of the milk and plasma data shows the parallel disposition of the drug in milk and plasma with a milk-plasma concentration ratio of 1.08 +/- 0.23. In conclusion, the persistence of the drug in plasma is reflected in the duration of the presence of ivermectin in milk.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8260963

Source DB:  PubMed          Journal:  Vet Res        ISSN: 0928-4249            Impact factor:   3.683


  14 in total

1.  Some pharmacokinetic parameters of eprinomectin in goats following pour-on administration.

Authors:  M Alvinerie; E Lacoste; J F Sutra; C Chartier
Journal:  Vet Res Commun       Date:  1999-11       Impact factor: 2.459

2.  Lack of sex-influence on the in vitro metabolism of ivermectin by hepatic microsomal preparations from cattle.

Authors:  J Dupuy; C Eeckhoutte; J F Sutra; C Mage; M Alvinerie
Journal:  Vet Res Commun       Date:  1999-06       Impact factor: 2.459

Review 3.  A survey of the literature (1995-1999) on the kinetics of drugs in camels (Camelus dromedarius).

Authors:  A A Alquarawi; B H Ali
Journal:  Vet Res Commun       Date:  2000-05       Impact factor: 2.459

4.  Ivermectin in senegalese peulh sheep: influence of sex on plasma disposition.

Authors:  T Bengone Ndong; Y Kane; E H M Diouf; M Alvinerie
Journal:  Vet Res Commun       Date:  2007-01-27       Impact factor: 2.459

5.  Eprinomectin in dairy zebu Gobra cattle (Bos indicus): plasma kinetics and excretion in milk.

Authors:  T Bengone-Ndong; M A Ba; Y Kane; I Sané; J F Sutra; M Alvinerie
Journal:  Parasitol Res       Date:  2006-01-14       Impact factor: 2.289

6.  Treatment of Sarcoptic mange infestation in rabbits with long acting injectable ivermectin.

Authors:  Khan Sharun; Satheesh Anjana; Syed Aboobacker Sidhique; Shaji Panikkassery
Journal:  J Parasit Dis       Date:  2019-06-22

7.  Pharmacokinetics of eprinomectin in plasma and milk in lactating camels (Camelus dromedarius).

Authors:  M Bengoumi; K Hidane; F Van-Gool; M Alvinerie
Journal:  Vet Res Commun       Date:  2006-12-22       Impact factor: 2.459

8.  Ivermectin-loaded lipid nanocapsules: toward the development of a new antiparasitic delivery system for veterinary applications.

Authors:  G V Ullio Gamboa; S D Palma; A Lifschitz; M Ballent; C Lanusse; C Passirani; J P Benoit; D A Allemandi
Journal:  Parasitol Res       Date:  2016-02-06       Impact factor: 2.289

9.  Pharmacokinetics and efficacy of an ivermectin implant for long-term prevention of Dirofilaria immitis infection in dogs.

Authors:  Marco Genchi; Anne Geneteau; Patrick Forget; Romain Delcombel; Claudio Genchi
Journal:  Parasitol Res       Date:  2017-04-22       Impact factor: 2.289

Review 10.  Moxidectin and the avermectins: Consanguinity but not identity.

Authors:  Roger Prichard; Cécile Ménez; Anne Lespine
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-14       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.